Diabetes: Innovations, Outcomes and Personalized Therapies
joint with Unraveling the Secrets of Kidney Disease
Organizer(s): Philip J. Larsen, Melina Claussnitzer and Tina VilsbøllDate: March 03 - 07, 2019
Location: Whistler Conference Centre, Whistler, BC, Canada
Diabetes remains a public health challenge of epidemic proportions. Modern treatment algorithms are evolving to recommend greater focus on personalized approaches to diabetes care. However, as diabetes remains a disease characterized by excess elevation of a plasma biomarker, glucose, further refinement of our understanding of the disease and its comorbidities is required to provide optimal guidance for precision medicine. Advancement of research technologies and the ability to handle large data sets have enabled systems biology approaches to unravel different etiologies and pathophysiological consequences of diabetes. Future diabetes discovery efforts will focus on pairing knowledge about genetic risk and environmental triggers of diabetes-associated pathologies. Using deep phenome characterization and molecular network analyses diabetes, researchers will be able to launch modern translational approaches to diabetes care innovation. The objectives of the conference are to provide directional guidance for future pressure points of diabetes care and focus on specific diabetes complications representing particular unmet needs. Further, cutting-edge discoveries of genetic risk determinants and their molecular mechanisms will be presented together with lively debates about the translatability of such insights into novel curative therapies.
Scholarship Deadline: November 19 2018
Discounted Abstract Deadline: November 19 2018
Abstract Deadline: December 19 2018
Discounted Registration Deadline: January 11 2019
We gratefully acknowledge additional support from these exhibitors at this conference:
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 5R13DK104616-05
Funding for this conference was made possible (in part) by 5R13DK104616-05 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.